Main Content start here

Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 289.21 million

CAGR (2023-2028)

7.62%

Fastest Growing Segment

Urinary Antigen Test (UAT)

Largest Market

North America

Market Overview

Global Legionella Testing Market has valued at 289.21 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.62% through 2028. Legionella testing is a diagnostic procedure used to detect the presence of Legionella bacteria in water sources, particularly in building water systems, cooling towers, hot tubs, spas, and other aquatic environments. Legionella bacteria are known to cause Legionnaires' disease, a severe and potentially fatal form of pneumonia, as well as a milder illness called Pontiac fever when inhaled or aspirated in water droplets or aerosols. Legionella testing typically involves collecting water samples from various points within a water distribution system, including taps, showers, or cooling towers. These samples are then analyzed in a laboratory to identify the presence and concentration of Legionella bacteria. Various testing methods are available, including culture-based methods, PCR (polymerase chain reaction) techniques, and immunoassays. The Global Legionella Testing Market is a vital component of public health and safety, focusing on the detection and prevention of Legionnaires' disease, a potentially severe respiratory illness caused by the Legionella bacteria. This market has witnessed significant growth due to increasing awareness, stringent regulatory requirements, and the rising occurrence of Legionella-related outbreaks. Key factors driving this market include the increasing number of Legionnaires' disease cases, particularly in high-risk environments like healthcare facilities, hotels, and cooling tower systems. The implementation of stringent regulations and guidelines by health authorities and governments worldwide has mandated routine Legionella testing in these facilities, contributing to market growth. In addition to traditional culture-based testing methods, molecular techniques like PCR (Polymerase Chain Reaction) have gained popularity for their rapid and accurate detection capabilities. These advancements in testing technology have provided healthcare professionals, building managers, and water treatment specialists with more effective tools for identifying and mitigating Legionella contamination. The COVID-19 pandemic has further underscored the importance of Legionella testing, as water stagnation in buildings during lockdowns increased the risk of bacterial growth. Consequently, this has prompted increased testing and water management efforts to ensure safe water quality. As the need for Legionella testing continues to grow in response to these factors, the Global Legionella Testing Market is expected to expand, with technological innovations and increased awareness playing pivotal roles in its sustained development. This market serves as a critical component of public health infrastructure, helping to prevent outbreaks and protect individuals from Legionella-related illnesses.

Key Market Drivers

Rising Incidence of Legionnaires' Disease

The rising incidence of Legionnaires' disease is a significant driver of the Global Legionella Testing Market. Legionnaires' disease is a severe and potentially life-threatening form of pneumonia caused by the inhalation of Legionella bacteria-contaminated water droplets or aerosols. Several factors contribute to the increasing occurrence of this disease, thereby necessitating heightened vigilance and testing: Aging Infrastructure: Many buildings and industrial facilities, particularly in developed countries, have aging water systems that may provide conducive conditions for Legionella growth. Corroded pipes, biofilm buildup, and poor maintenance can create environments where Legionella bacteria can thrive. Climate Change: Changes in weather patterns, including higher temperatures and increased humidity, can favor the proliferation of Legionella bacteria in water systems. Climate-related factors can lead to more favorable conditions for bacterial growth. Urbanization and Construction: Rapid urbanization and construction activities can disrupt water systems, leading to stagnant water, which is a breeding ground for Legionella. New buildings and renovations may introduce risks if not properly managed. Increased Awareness and Reporting: Improved awareness among healthcare professionals and the public about Legionnaires' disease has led to more accurate diagnoses and reporting. As a result, a higher number of cases are being documented. Aging Population: Legionnaires' disease primarily affects older individuals and those with weakened immune systems. The aging global population is more susceptible to this illness, increasing the overall incidence. Travel and Tourism: International travel and tourism contribute to the spread of Legionella bacteria, especially in hotels and resorts. Travelers may contract the disease and carry it to other regions, necessitating testing for prevention. Healthcare Facilities: Hospitals and healthcare settings can be at risk due to their complex water systems and the vulnerability of their patient populations. Legionella testing is crucial in these environments to protect patients and staff. Regulatory Compliance: Stringent regulations in many regions mandate Legionella testing in certain facilities, further increasing the number of tests conducted. In response to the rising incidence of Legionnaires' disease and the associated public health concerns, Legionella testing has become an essential tool in identifying and mitigating outbreaks. This trend is expected to continue to drive the Global Legionella Testing Market as the importance of water safety and disease prevention remains a top priority.

High-Risk Environments

High-risk environments, in the context of the Global Legionella Testing Market, refer to specific settings where conditions are conducive to the growth and proliferation of Legionella bacteria, increasing the risk of Legionnaires' disease outbreaks. These environments often necessitate regular Legionella testing and water management strategies to mitigate the risk effectively. Several characteristics define these high-risk settings: Complex Water Systems: Facilities with intricate water distribution systems, such as hospitals, hotels, apartment complexes, and large industrial sites, are at greater risk. These systems can include cooling towers, hot water tanks, and extensive plumbing networks, providing numerous opportunities for Legionella colonization. Stagnation: Water stagnation or low flow in pipes and fixtures can create ideal conditions for Legionella growth. In high-risk environments, there may be periods of reduced water use or occupancy, allowing the bacteria to multiply within the water system. Warm Water Temperatures: Legionella bacteria thrive in warm water, particularly between 77°F (25°C) and 113°F (45°C). In some environments, such as heated water tanks or cooling towers, the water temperature may fall within this optimal range. Biofilm Formation: Biofilms, slimy layers of microorganisms that adhere to surfaces within water systems, provide a protective environment for Legionella bacteria to multiply. High-risk environments often have conditions conducive to biofilm formation. Aerosol Generation: Activities that generate water aerosols, such as showers, hot tubs, and cooling towers, can aerosolize Legionella-contaminated water, making it more likely to be inhaled by individuals, increasing the risk of infection. Vulnerable Populations: High-risk environments often house populations more susceptible to Legionnaires' disease, such as the elderly, individuals with compromised immune systems, or patients in healthcare facilities. Infrequent or Poor Maintenance: Inadequate maintenance of water systems, including insufficient disinfection and cleaning procedures, can create opportunities for Legionella to proliferate. Due to the elevated risk associated with these environments, regulatory authorities in many regions have mandated Legionella testing and water management programs to ensure water safety and compliance with health and safety standards. As a result, the Global Legionella Testing Market plays a crucial role in identifying and addressing the presence of Legionella bacteria in these settings, helping to prevent Legionnaires' disease outbreaks and protect public health.

Advancements in Testing Technology

Advancements in testing technology have significantly impacted the Global Legionella Testing Market, enhancing the speed, accuracy, and accessibility of Legionella detection methods. These innovations have played a pivotal role in improving the efficiency and effectiveness of Legionella testing, driving market growth. Key advancements include: Polymerase Chain Reaction (PCR) Techniques: PCR-based methods have revolutionized Legionella testing by allowing for rapid and highly sensitive detection of Legionella DNA. This technology enables the identification of Legionella species in a matter of hours, as opposed to the days required for traditional culture-based methods. PCR has become a preferred choice for both environmental and clinical samples, aiding in faster response to potential outbreaks. Next-Generation Sequencing (NGS): NGS technologies have expanded the scope of Legionella testing by providing comprehensive genetic information. These techniques can identify not only the presence of Legionella but also their genetic diversity, which can be crucial for outbreak investigations and source tracking. Automation: Automation has streamlined the Legionella testing process, reducing human error and increasing throughput. Automated systems can process a larger number of samples efficiently, making Legionella testing more accessible and cost-effective. Remote Monitoring and Digital Tools: Digital innovations, including remote monitoring and data analysis, have improved the management of Legionella risk. Real-time monitoring of water systems and the use of data analytics help identify potential issues and enable proactive measures to prevent Legionella growth. Point-of-Care Testing (POCT): POCT devices are becoming more accessible for rapid Legionella testing in clinical settings. These portable and user-friendly tools enable healthcare professionals to obtain quick results at the bedside, aiding in timely patient diagnosis and treatment. Multiplex Assays: Multiplex assays can simultaneously detect multiple pathogens, including Legionella, in a single test. This technology offers greater efficiency and cost savings in situations where multiple pathogen screening is required. Improved Culture Methods: Traditional culture-based methods have also seen refinements, with more selective media and culture techniques that enhance Legionella recovery rates while reducing false negatives. These advancements have not only improved the accuracy and efficiency of Legionella testing but have also made it more accessible to a wider range of industries and facilities. As a result, the Global Legionella Testing Market is poised for continued growth as technological innovations continue to shape the landscape of Legionella detection and prevention.

International Travel and Tourism

International travel and tourism play a significant role in the Global Legionella Testing Market due to their potential to contribute to the spread of Legionella bacteria and the need for preventive measures. Here's an overview of the relevance of international travel and tourism: Cross-Border Transmission: Travelers can unknowingly carry Legionella bacteria from one location to another, especially when staying in hotels, resorts, or cruise ships. If these facilities have contaminated water systems, travelers may be exposed to the bacteria, leading to potential infections. Diverse and Mobile Population: The global tourism industry welcomes millions of travelers from diverse geographical locations. These travelers may come from areas with varying Legionella contamination levels, which increases the risk of exposure in destinations with inadequate water management. Hotels and Accommodations: Hotels and resorts are known for their complex plumbing systems, including pools, hot tubs, and showers—ideal environments for Legionella growth. Travelers can be at risk of inhaling Legionella-contaminated aerosols in these facilities. Cruise Ships: Cruise ships are a unique concern, as they have their own water systems and often carry passengers from various countries. Outbreaks of Legionnaires' disease on cruise ships have been documented, emphasizing the need for Legionella testing and control measures in this sector. Public Health Concerns: Outbreaks linked to travel destinations can have international public health implications. Identifying the source of an outbreak and preventing further transmission often requires collaboration between multiple countries and health organizations. Regulatory Variations: Different countries have varying regulations and guidelines related to Legionella testing and water quality management. Travel and tourism industry stakeholders need to be aware of and compliant with these regional differences. In response to these concerns, many countries and regions have implemented regulations and recommendations for Legionella testing and water management in tourist accommodations. Additionally, international travel and tourism industry associations have recognized the importance of Legionella prevention and have provided guidelines for their members. The role of international travel and tourism in the Global Legionella Testing Market underscores the need for standardized testing protocols and global cooperation to ensure the safety of travelers and prevent the cross-border spread of Legionella-related illnesses. Travelers and travel industry professionals alike benefit from proactive Legionella testing and prevention measures.


Download Free Sample Report

 

Key Market Challenges

Complex Testing Protocols

Complex testing protocols refer to the intricate and multi-step procedures involved in Legionella testing within the Global Legionella Testing Market. These protocols are designed to detect the presence of Legionella bacteria in water samples accurately. However, they can present several challenges and complexities: Sample Collection: The process begins with sample collection, which requires selecting appropriate sampling points in a facility's water distribution system. Identifying these points and ensuring representative sampling can be challenging, especially in large and intricate systems. Sample Transportation: Once collected, water samples must be carefully transported to the laboratory for analysis. Maintaining the integrity of the samples during transit is crucial to obtaining accurate results. Laboratory Analysis: In the laboratory, Legionella testing involves several techniques, including culture-based methods, PCR (Polymerase Chain Reaction), and Next-Generation Sequencing (NGS). Each method has its specific requirements and complexities, ranging from the time-consuming nature of culture-based methods to the need for specialized equipment in molecular techniques. Quality Control: Ensuring the reliability and accuracy of testing results requires rigorous quality control measures. Laboratories must adhere to strict standards to validate their methods, including regular calibration of equipment and proficiency testing. Data Interpretation: Interpreting test results can be challenging, especially when Legionella bacteria are detected at low levels. Skilled personnel are needed to assess the significance of findings and determine appropriate follow-up actions. Reporting and Communication: Accurate reporting of results and effective communication with facility managers and public health authorities are critical. Miscommunication or delays in reporting can lead to inadequate response measures in the event of Legionella detection. Regulatory Compliance: Meeting regulatory requirements adds an additional layer of complexity. Different regions may have varying regulations and guidelines regarding Legionella testing, necessitating thorough understanding and compliance. Data Management: Managing and archiving large volumes of testing data can be challenging. Effective data management systems are essential for tracking trends and ensuring data integrity. These complex testing protocols underscore the need for standardized and well-documented procedures to ensure consistency, accuracy, and reliability in Legionella testing. Simplifying and streamlining these processes, along with the use of advanced technologies, can help mitigate some of the complexities associated with Legionella testing, ultimately enhancing the market's effectiveness in preventing Legionnaires' disease outbreaks.

Sampling Issues

Sampling issues are a critical aspect of the Global Legionella Testing Market, often presenting challenges in the accurate detection of Legionella bacteria in water systems. These challenges stem from various factors related to the collection of water samples for testing: Representativeness: Obtaining representative samples is crucial for Legionella testing. The location and frequency of sampling points must be carefully chosen to reflect the true conditions of the entire water distribution system. In large or complex systems, identifying these points can be challenging. Stagnation: Legionella bacteria tend to proliferate in stagnant water, making it important to collect samples from areas where water flow may be limited or where water can stagnate, such as dead-end pipes or infrequently used outlets. Identifying such locations within a facility can be complex. Biofilm Considerations: Legionella often reside within biofilms, which are slimy layers of microorganisms that attach to surfaces within water systems. Effective sampling should consider the presence of biofilms, as these can harbor Legionella and affect the accuracy of results. Sampling Methods: The choice of sampling methods and equipment can impact the quality of the samples. Different techniques, such as swabbing, grab sampling, or continuous monitoring, may be required based on the specific testing objectives and the characteristics of the water system. Sample Volume and Timing: Collecting an adequate volume of water and sampling at the right time of day can influence the sensitivity of Legionella testing. Variations in sample volume and timing can lead to inconsistent results. Frequency: Determining the appropriate frequency of sampling is essential. Factors such as facility type, water system complexity, and local regulations influence the testing schedule. Frequent testing can be resource-intensive and may require careful planning. Sample Handling: Proper handling of samples during collection, transportation, and storage is critical to maintaining sample integrity. Contamination during these stages can lead to inaccurate results. Addressing these sampling challenges requires a thorough understanding of the specific water system, the application of standardized sampling protocols, and skilled personnel. To improve accuracy and reliability, technological advancements, such as automated sampling systems and real-time monitoring, have been introduced to simplify the sampling process and reduce human errors, thereby enhancing the effectiveness of Legionella testing in preventing Legionnaires' disease outbreaks.

Key Market Trends

Advancements in Testing Technologies

Advancements in testing technologies have significantly influenced the Global Legionella Testing Market by revolutionizing the detection and prevention of Legionnaires' disease. These technological innovations have not only improved the speed and accuracy of Legionella testing but have also made it more accessible and cost-effective. Key advancements include: Polymerase Chain Reaction (PCR) Methods: PCR-based testing techniques have gained prominence in Legionella detection. These methods amplify and detect Legionella DNA, enabling rapid and highly sensitive identification of the bacteria. PCR has become a preferred choice for Legionella testing, offering faster results compared to traditional culture-based methods. Next-Generation Sequencing (NGS): NGS technologies have expanded the scope of Legionella testing by providing comprehensive genetic information about the bacteria. This allows for the identification of Legionella species and their genetic diversity, aiding in outbreak investigations and source tracking. Automated Testing Systems: Automation has streamlined Legionella testing, reducing human error and increasing throughput. Automated systems can process a larger number of samples efficiently, making Legionella testing more accessible and cost-effective. Point-of-Care Testing (POCT): POCT devices are becoming increasingly available for rapid Legionella testing in clinical settings. These portable and user-friendly tools enable healthcare professionals to obtain quick results at the bedside, aiding in timely patient diagnosis and treatment. Multiplex Assays: Multiplex assays can simultaneously detect multiple pathogens, including Legionella, in a single test. This technology offers greater efficiency and cost savings, particularly in situations where multiple pathogen screening is required. Improved Culture Methods: Traditional culture-based methods have also seen refinements, with more selective media and culture techniques that enhance Legionella recovery rates while reducing false negatives. These advancements not only improve the accuracy and efficiency of Legionella testing but also make it more accessible to a wider range of industries and facilities. Additionally, they play a crucial role in the early detection of Legionella contamination, enabling timely preventive measures and contributing to the market's growth as the importance of Legionella prevention continues to rise.

International Collaboration

International collaboration is becoming increasingly crucial in the context of the Global Legionella Testing Market due to the transboundary nature of Legionella outbreaks and the shared responsibility in preventing them. Here's an overview of the significance of international collaboration: Information Sharing: Legionella outbreaks can occur in one country and affect travelers from various parts of the world. Timely and transparent sharing of information about outbreak situations, including genetic data and strain typing, helps pinpoint the source of contamination and implement effective control measures. Harmonization of Guidelines: Different countries have varying regulations and guidelines related to Legionella testing and water management. International collaboration fosters harmonization efforts, aligning standards to ensure consistency and effectiveness in Legionella prevention. Cross-Border Outbreak Investigations: Legionella outbreaks often require cross-border investigations to determine the source and prevent further spread. Collaboration between countries facilitates these investigations and ensures coordinated responses. Research and Best Practices: Sharing research findings, best practices, and lessons learned from Legionella-related incidents contributes to a global knowledge pool. This knowledge exchange helps countries improve their prevention and testing strategies. Global Standards: Collaborative efforts can lead to the development of global standards for Legionella testing, water management, and prevention, enhancing the effectiveness of these measures worldwide. Capacity Building: Collaborative initiatives can provide training and capacity-building opportunities for professionals involved in Legionella testing and prevention. This ensures that a skilled workforce is available globally to address Legionella risks. Response to Emerging Threats: In the face of emerging Legionella threats, such as new strains or sources of contamination, international collaboration enables a coordinated response to mitigate risks and protect public health. Cross-Continental Travel: The movement of people across continents exposes them to varying Legionella risks. Collaboration helps ensure that travelers are adequately protected, and that preventive measures are consistent across different regions. Global Preparedness: In an era of increasing global travel and climate change, international collaboration enhances global preparedness to respond to Legionella outbreaks, preventing them from becoming pandemics. As the Global Legionella Testing Market continues to grow and evolve, international collaboration will play a pivotal role in addressing the challenges and complexities associated with Legionella prevention. It underscores the shared commitment to protecting public health across borders and the collective responsibility to prevent and control Legionella-related risks.

Segmental Insights

Test Type Insights

In 2022, the Legionella Testing Market was dominated by the Urinary Antigen Test (UAT) segment and is predicted to continue expanding over the coming years. This is because it provides rapid outcomes, with usually same-day results. Additionally, UAT is not resource-specific and technically intensive like culture-based tests


Download Free Sample Report

Regional Insights

In 2022, the Global Legionella Testing Market was dominated by the North America segment and is predicted to continue expanding over the coming years. This is ascribed due to increasing cases of patients suffering from legionella infections and the presence of key players in this region.

Recent Development

In May 2022, ChemREADY, manufacturer of water and wastewater treatment chemicals, announced the debut of its new Legionella testing services and product line to battle the water-borne infection in building water systems.

In March 2022, IDEXX has reported that the Legiolert test, for the rapid detection of Legionella pneumophila, has been published by ASTM International as “ASTM D8429-21: Standard Test Method for Legionella pneumophila in Water Samples Using Legiolert.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • BioMérieux SA
  • Becton, Dickinson and Company
  • Aquacert Ltd
  • Qiagen NV
  • Bio-Rad Laboratories
  • Hologic Inc.
  • Takara Bio Inc.
  • Beckman Coulter Inc.
  • Roche Diagnostics

 

By Test Type

By Application

By End User

By Region

  • Culture Method
  • Urinary Antigen Test (UAT)
  • Direct Fluoroscent Antibody (DFA) Test
  • Polymerase Chain Reaction (PCR)
  • Other
  • Clinical Testing Method
  • Environmental Testing
  •  Method
  • Hospital and Clinics
  • Diagnostics Laboratory
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Legionella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Legionella Testing Market, By Test Type:

o   Culture Method

o   Urinary Antigen Test (UAT)

o   Direct Fluoroscent Antibody (DFA) Test

o   Polymerase Chain Reaction (PCR)

o   Other

  • Global Legionella Testing Market, By Application:

o   Clinical Testing Method

o   Environmental Testing Method

  • Global Legionella Testing Market, By End User:

o   Hospital and Clinics

o   Diagnostics Laboratory

  • Global Legionella Testing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Legionella Testing Market.

Available Customizations:

Global Legionella Testing Market report with the given Market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).
Global Legionella Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]


Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Global Legionella Testing Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Test Type (Culture Method, Urinary Antigen Test (UAT), Direct Fluoroscent Antibody (DFA) Test, Polymerase Chain Reaction (PCR), Other)

5.2.2.    By Application (Clinical Testing Method and Environmental Testing Method)

5.2.3.    By End User (Hospital and Clinics, Diagnostics Laboratory)

5.2.4.    By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.5.    By Company (2022)

5.3.  Product Market Map

5.3.1.    By Test Type

5.3.2.    By Application

5.3.3.    By Region

6.    North America Legionella Testing Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Test Type

6.2.2.    By Application

6.2.3.    By End User

6.2.4.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Legionella Testing Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Test Type

6.3.1.2.2.           By Application

6.3.1.2.3.           By End User

6.3.2.    Canada Legionella Testing Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Test Type

6.3.2.2.2.           By Application

6.3.2.2.3.           By End User

6.3.3.    Mexico Legionella Testing Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Test Type

6.3.3.2.2.           By Application

6.3.3.2.3.           By End User

7.    Europe Legionella Testing Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Test Type

7.2.2.    By Application

7.2.3.    By End User

7.2.4.    By Country

7.3.  Europe: Country Analysis

7.3.1.    Germany Legionella Testing Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Test Type

7.3.1.2.2.           By Application

7.3.1.2.3.           By End User

7.3.2.    France Legionella Testing Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Test Type

7.3.2.2.2.           By Application

7.3.2.2.3.           By End User

7.3.3.    United Kingdom Legionella Testing Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Test Type

7.3.3.2.2.           By Application

7.3.3.2.3.           By End User

7.3.4.    Italy Legionella Testing Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           By Test Type

7.3.4.2.2.           By Application

7.3.4.2.3.           By End User

7.3.5.    Spain Legionella Testing Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           By Test Type

7.3.5.2.2.           By Application

7.3.5.2.3.           By End User

8.    Asia-Pacific Legionella Testing Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Test Type

8.2.2.    By Application

8.2.3.    By End User

8.2.4.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Legionella Testing Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Test Type

8.3.1.2.2.           By Application

8.3.1.2.3.           By End User

8.3.2.    Japan Legionella Testing Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Test Type

8.3.2.2.2.           By Application

8.3.2.2.3.           By End User

8.3.3.    India Legionella Testing Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Test Type

8.3.3.2.2.           By Application

8.3.3.2.3.           By End User

8.3.4.    South Korea Legionella Testing Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Test Type

8.3.4.2.2.           By Application

8.3.4.2.3.           By End User

8.3.5.    Australia Legionella Testing Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Test Type

8.3.5.2.2.           By Application

8.3.5.2.3.           By End User

9.    South America Legionella Testing Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Test Type

9.2.2.    By Application

9.2.3.    By End User

9.2.4.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Legionella Testing Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Test Type

9.3.1.2.2.           By Application

9.3.1.2.3.           By End User

9.3.2.    Argentina Legionella Testing Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Technology

9.3.2.2.2.           By Application

9.3.2.2.3.           By End User

9.3.3.    Colombia Legionella Testing Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Test Type

9.3.3.2.2.           By Application

9.3.3.2.3.           By End User

10. Middle East and Africa Legionella Testing Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Test Type

10.2.2. By Application

10.2.3. By End User

10.2.4. By Country

10.3.             MEA: Country Analysis

10.3.1. UAE Legionella Testing Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Test Type

10.3.1.2.2.         By Application

10.3.1.2.3.         By End User

10.3.2. Saudi Arabia Legionella Testing Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Test Type

10.3.2.2.2.         By Application

10.3.2.2.3.         By End User

10.3.3. South Africa Legionella Testing Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Test Type

10.3.3.2.2.         By Application

10.3.3.2.3.         By End User

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Merger & Acquisition

12.2.             Product Development

12.3.             Recent Developments

13. Porter’s analysis

14. PESTEL analysis

15. Competitive Landscape

15.1.             Business Overview

15.2.             Company Snapshot

15.3.             Products & Services

15.4.             Financials (As Reported)

15.5.             Recent Developments

15.5.1. Thermo Fisher Scientific Inc.

15.5.2. BioMérieux SA

15.5.3. Becton, Dickinson and Company

15.5.4. Aquacert Ltd

15.5.5. Qiagen NV

15.5.6. Bio-Rad Laboratories

15.5.7. Hologic Inc.

15.5.8. Takara Bio Inc.

15.5.9. Beckman Coulter Inc.

15.5.10.              Roche Diagnostics

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The Market size of the Global Legionella Testing Market was estimated to be USD 289.21 million in 2022

down-arrow

Thermo Fisher Scientific Inc., BioMérieux SA, Becton, Dickinson and Company, Aquacert Ltd, Qiagen NV, Bio-Rad Laboratories , Hologic Inc., Takara Bio Inc. , Beckman Coulter Inc. , Roche Diagnostics etc. are some of the key players operating in the Global Legionella Testing Market.

down-arrow

Legionella testing often requires complex procedures, including sample collection, transportation, and laboratory analysis. Ensuring that these steps are carried out accurately and consistently can be challenging are some of the major challenges faced by the Global Legionella Testing Market in the upcoming years

down-arrow

The increasing occurrence of Legionnaires' disease cases globally is a significant driver. This respiratory illness, caused by Legionella bacteria, has prompted heightened awareness and the need for regular testing to prevent outbreaks, driving the demand for reagents are the major drivers for the Global Legionella Testing Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Legionella Testing Market to Grow with a CAGR of 7.62% through 2028

Dec, 2023

Rising prevalence of chronic diseases are expected to drive the Global Legionella Testing Market in the forecast period 2024-2028